Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program
New program will increase access to affordable genetic testing while also helping to identify and…
Month: April 2023
PDS Biotech to Host Interleukin 12 (IL-12) Immunocytokine-Focused KOL Roundtable on April 21, 2023
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
PDS Biotech to Host Interleukin 12 (IL-12) Immunocytokine-Focused KOL Roundtable on April 21, 2023
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion system First…
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion system First…
ViCentra to Participate at the upcoming MedTech Strategist Innovation Summit and LSX London Conference
UTRECHT, The Netherlands, April 12, 2023 (GLOBE NEWSWIRE) — ViCentra B.V., the company behind Kaleido,…
ViCentra to Participate at the upcoming MedTech Strategist Innovation Summit and LSX London Conference
UTRECHT, The Netherlands, April 12, 2023 (GLOBE NEWSWIRE) — ViCentra B.V., the company behind Kaleido,…
Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference
LONDON, April 12, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…
Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference
LONDON, April 12, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…
Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company…
Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company…
Viridian Therapeutics Appoints Tony Casciano as Chief Commercial Officer
WALTHAM, Mass., April 12, 2023 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company…
Verizon Business returns with 5G Innovation Session Tour, kicking-off in Chicago
Verizon Business launches the 2023 5G Innovation Session Tour with Ericsson at Soldier Field on…
Verizon Business returns with 5G Innovation Session Tour, kicking-off in Chicago
Verizon Business launches the 2023 5G Innovation Session Tour with Ericsson at Soldier Field on…
Verizon upgrades network for San Francisco customers
Upgraded network creates platform for innovation for developers and enterprises SAN FRANCISCO, April 12, 2023…
Verizon upgrades network for San Francisco customers
Upgraded network creates platform for innovation for developers and enterprises SAN FRANCISCO, April 12, 2023…
Verizon and the City of Virginia Beach team up to keep people connected and safe
VIRGINIA BEACH, Va., April 12, 2023 (GLOBE NEWSWIRE) — Along the famous three mile boardwalk…
Baffle Joins AWS ISV Accelerate Program
Data-Centric Security Platform Helps Amazon Web Services Customers Reduce the Risk of Data Breaches, Improve…
Baffle Joins AWS ISV Accelerate Program
Data-Centric Security Platform Helps Amazon Web Services Customers Reduce the Risk of Data Breaches, Improve…
Descope Launches Startup Program For Frictionless, Secure Authentication
Program Provides Authentication and User Management Free of Charge for One Year LOS ALTOS, Calif.,…